Cardia Bioplastics (ASX:CNN) EV-to-Revenue : 0.34 (As of May. 21, 2024)

View and export this data going back to . Start your Free Trial

What is Cardia Bioplastics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cardia Bioplastics's enterprise value is A$5.81 Mil. Cardia Bioplastics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$17.27 Mil. Therefore, Cardia Bioplastics's EV-to-Revenue for today is 0.34.

The historical rank and industry rank for Cardia Bioplastics's EV-to-Revenue or its related term are showing as below:

ASX:CNN' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.28 Med: 0.8 Max: 6.24
Current: 0.89

During the past 13 years, the highest EV-to-Revenue of Cardia Bioplastics was 6.24. The lowest was 0.28. And the median was 0.80.

ASX:CNN's EV-to-Revenue is ranked better than
61.2% of 384 companies
in the Packaging & Containers industry
Industry Median: 1.09 vs ASX:CNN: 0.89

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-21), Cardia Bioplastics's stock price is A$0.00. Cardia Bioplastics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00. Therefore, Cardia Bioplastics's PS Ratio for today is .

Cardia Bioplastics EV-to-Revenue Historical Data

The historical data trend for Cardia Bioplastics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardia Bioplastics EV-to-Revenue Chart

Cardia Bioplastics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-Revenue

Get a 7-Day Free Trial

0.64

1.01

4.24

1.67

1.01

Cardia Bioplastics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															-	1.67	-	1.01	-

Competitive Comparison of Cardia Bioplastics's EV-to-Revenue

For the Packaging & Containers subindustry, Cardia Bioplastics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cardia Bioplastics's EV-to-Revenue Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Cardia Bioplastics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cardia Bioplastics's EV-to-Revenue falls into.

Cardia Bioplastics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cardia Bioplastics's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	5.807	/	17.27
	=	0.34

Cardia Bioplastics's current Enterprise Value is A$5.81 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cardia Bioplastics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$17.27 Mil.

Cardia Bioplastics (ASX:CNN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cardia Bioplastics's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.00	/
	=

Cardia Bioplastics's share price for today is A$0.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00.

Cardia Bioplastics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cardia Bioplastics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardia Bioplastics (ASX:CNN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Cardia Bioplastics Ltd (ASX:CNN) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

SES:Australia

Address

247 Ferntree Gully Road, Unit 1, Mount Waverley, Melbourne, VIC, AUS, VIC 3149

Website

https://www.secosgroup.com.au

SECOS Group Ltd is an Australian developer and manufacturer of sustainable packaging materials. . Business operating segment includes the manufacture and distribution of polyethylene films, renewable resource-based resins, and finished products. It supplies proprietary biodegradable resins, packaging products cast films to a customer base spread globally.SECOS Global Application Development Centre is in Australia. Product Development Centre and manufacturing plant for resins and finished products in China and resins plant in Malaysia. It also has manufacturing plants for cast films in Malaysia. It conducts sales via geographical regions that include Australia, Asia, America, Europe, and Africa. Asia generates maximum revenue for the company.

Cardia Bioplastics (ASX:CNN) Headlines

No Headlines